MAPK3 and Alzheimer disease: Among the most prominent kinases involved in TAU hyperphosphorylation in AD are ERK1/2, CDK5, and GSK3B (Mandelkow et al, 1995), and in silico analysis (Targetscan 7.0) predicts ERK1, ERK2, GSK3b, and TAU itself as putative miR‐132 targets in human and mouse.